Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function

Suttorp, Maarten J.; Kingma, J. H.; Koomen, Egbert M.; Hof, Arnoud van’t; Tijssen, Jan G.P.; Lie, Kong I.

doi:10.1016/0002-9149(93)91015-a

Cited by 152 publications

(68 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Forleo et al [10] reported that women undergoing AF ablation are older, have longer AF history and more comorbidities, however, they found no differences in AF recurrence compared with men. This observation is consistent with other results showing that women have higher rate of AF/AFl recurrence after cardioversion [11]. This is interesting especially when compared with a suggestion of Kerr and Humphries [12] that successful interventional treatment might be particularly useful to improve the quality of life in women with AF.…”

Section: Discussionsupporting

confidence: 91%

Readmissions and repeat procedures after catheter ablation for atrial fibrillation

et al. 2015

View full text Add to dashboard Cite

(56.6 ± 11.0 vs. 59.1 ± 10.8; p = 0.019) and the time of the index hospitalization was shorter (3.75 ± 2.16 vs. 4.45 ± 3.26; p = 0.03). Within 30 days 194 (9.6%) patients were hospitalized and 747 (36.9%) in 1-year follow-up. All-cause mortality was 0. 1% and 1.4% in 30-day and 1-year follow-up, respectively. In a 1-year follow-up patients hospitalized from AF/AFl recurrence were more frequently hospitalized due to cardiovascular diseases other than AF/AFl (9.6% vs. 6.7%; p = 0.026), especially due to hypertension (2.9% vs. 0.7%; p < 0.001). Conclusions: Over 1 out of 4 patients who underwent AF/AFl ablation were hospitalized due to arrhythmia recurrence in 1 year. (Cardiol J 2015; 22, 6: 630-636)

show abstract

Section: Discussionsupporting

confidence: 91%

Readmissions and repeat procedures after catheter ablation for atrial fibrillation

et al. 2015

View full text Add to dashboard Cite

show abstract

“…When a patient's ECG documentation had not been obtained, an episode of PAF was decided if the patient's history revealed a symptomatic episode of a rapid, grossly irregular heart beat lasting at least 10 min. 18 Twelve-Lead Surface Electrocardiogram P-wave duration was calculated in all simultaneously recorded 12 leads of the surface ECG. P-wave duration measurements were obtained manually by two of the investigators blinded to the history of patients by using calipers and a magnifying lens for accurate definition of the ECG deflection as defined in previous studies.…”

Section: Documentation Of Paroxysmal Atrial Fibrillationmentioning

confidence: 99%

Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P‐wave dispersion

Köse

Aytemir

Sade

et al. 2003

Clinical Cardiology

View full text Add to dashboard Cite

SummaryBackground: Paroxysmal atrial fibrillation (PAF) in hypertrophic cardiomyopathy (HCM) is associated with poor prognosis. Previous studies have shown good correlation between P-wave dispersion (Pd) and occurrence of PAF. However, Pd in patients with HCM for predicting PAF has not been studied.Hypothesis: The aim of the study was to determine whether Pd could identify patients with HCM who are likely to suffer from PAF.Methods: Twenty-two patients with HCM with a history of PAF (Group 1) and 26 patients with HCM without a history of PAF (Group 2) were studied. Maximum (Pmax) and minimum (Pmin) P-wave durations, as well as P-wave dispersion (Pd = Pmax ϪPmin) were calculated from 12-lead surface electrocardiograms (ECG).Results: P-wave dispersion was significantly different between the groups (Group 1: 55 ± 6 ms vs. Group 2: 37 ± 8 ms; p < 0.001), while Pmax (Group 1: 134 ± 11 ms vs. Group 2: 128 ± 13 ms; p = 0.06) and Pmin (Group 1: 78 ± 9 ms vs. Group 2: 81 ± 7 ms; p = 0.07) was not significantly different. Patients with a history of PAF had higher left atrial diameter than the patients without PAF (Group 1: 52 ± 8 mm vs. Group 2: 48 ± 10 mm; p = 0.02). A cut-off value of 46 ms for Pd had a sensitivity of 76% and a specificity of 82% in discriminating between patients with and without PAF.Conclusion: This study suggests that P-wave dispersion could identify patients with HCM who are likely to develop PAF.

show abstract

“…Evidence that women may be more symptomatic than men during atrial fibrillation comes from data by Hnatkova et al, 28 who found that in women the duration of paroxysmal atrial fibrillation episodes was found to be longer and the heart rate higher than in their male counterparts. Suttorp et al 29 have published data suggesting that maintenance of sinus rhythm may be more difficult in women after cardioversion, whether chemical or electrical. As will be discussed more fully below, women tend to experience proarrhythmias from antiarrhythmic therapy more frequently than men, which can complicate the medical management of their atrial fibrillation.…”

Section: Atrial Fibrillationmentioning

confidence: 99%

Gender differences in arrhythmias

Wolbrette

Naccarelli

Curtis

et al. 2002

Clinical Cardiology

103

View full text Add to dashboard Cite

Summary: Electrocardiographic and electrophysiologic differences between men and women have long been noted. Women have a higher intrinsic heart rate than men, along with a longer corrected QT interval and a shorter sinus nodal recovery time. The incidence of and risk factors for a variety of arrhythmias differ between men and women. Atrioventricular nodal reentry tachycardia has a 2:1 female-to-male predominance, while accessory pathways are twice as frequent in men. Although atrial fibrillation is more prevalent in men of all age groups, the absolute numbers of men and women with atrial fibrillation are equal, and the associated morbidity and mortality experienced by women with atrial fibrillation appear to be worse. Women have a lower incidence of sudden cardiac death, and female survivors of sudden cardiac death have a lower frequency of spontaneous or inducible ventricular tachycardia. On the other hand, drug-induced torsade de pointes and symptomatic long QT syndrome have a female predominance. Therefore, greater caution should be used when prescribing QT-prolonging drugs in women. The incidence of arrhythmias is increased during pregnancy, and management of pregnant patients poses a significant challenge. The mechanisms of these gender differences are unclear but may be related to hormonal effects and the shorter QT interval in adult males. Pharmacologic and nonpharmacologic therapies are usually equally efficacious, but the risks of pharmacologic therapy are different in men and women. Atrial fibrillation may be more difficult to treat in women.

show abstract

Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function

Cited by 152 publications

References 15 publications

Readmissions and repeat procedures after catheter ablation for atrial fibrillation

Readmissions and repeat procedures after catheter ablation for atrial fibrillation

Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P‐wave dispersion

Gender differences in arrhythmias

Contact Info

Product

Resources

About